Dr. med. Ariane Hammitzsch

Dr. med. Ariane Hammitzsch is a distinguished physician specializing in nephrology and rheumatology at the TUM Transplantation Center in Germany. With years of experience, Dr. Hammitzsch has made significant contributions to the field, as evidenced by her three scientific publications. Her research focuses on CBP30, a selective CBP/p300 bromodomain inhibitor, that suppresses human Th17 responses, showing her dedication to advancing understanding and treatment in this area. Working at the renowned TUM University Hospital, Klinikum rechts der Isar, Dr. Hammitzsch brings a wealth of knowledge and expertise to her practice, making her a trusted and respected professional in the medical community. Through her work at the university rheumatology outpatient clinic, she has shown resilience and adaptability, especially during the challenges posed by the COVID-19 pandemic. Dr. Hammitzsch's commitment to her patients and research makes her a standout in the field, ensuring high-quality care and innovative treatment approaches.